Evidence map›Paper›PMID 29158068›Full record

ArticleJournal of structural biology2018

New crystal forms of the integral membrane Escherichia coli quinol:fumarate reductase suggest that ligands control domain movement.

C A Starbird, Thomas M Tomasiak, Prashant K Singh, Victoria Yankovskaya, Elena Maklashina, Michael Eisenbach, Gary Cecchini, T M Iverson

Open access · greenAbstract read
In one paragraph

Article in Journal of structural biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Architecture of the mycobacterial succinate dehydrogenase with a membrane-embedded Rieske FeS cluster.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

C A StarbirdGraduate Program in Chemical and Physical Biology, Vanderbilt University, Nashville, TN 37232, United States.
Thomas M TomasiakDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States.
Prashant K SinghDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States.
Victoria YankovskayaMolecular Biology Division, San Francisco VA Health Care System, San Francisco, CA 94158, United States.
Elena MaklashinaMolecular Biology Division, San Francisco VA Health Care System, San Francisco, CA 94158, United States; Department of Biochemistry & Biophysics, University of California, San Francisco, CA 94158, United States.
Michael EisenbachDepartment of Biomolecular Sciences, Weizmann Institute of Science, Israel.
Gary CecchiniMolecular Biology Division, San Francisco VA Health Care System, San Francisco, CA 94158, United States.
T M IversonDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Department of Biochemistry, Vanderbilt University, Nashville, TN 37232, United States. Electronic address: tina.iverson@vanderbilt.edu.
Vanderbilt University · USSan Francisco VA Health Care System · USWeizmann Institute of Science · IL

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Structure/Function of Complex ll OxidoreductasesR01GM061606 · NIGMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI CECCHINI, GARY, IVERSON, T M · 2001 to 2022
$9.1M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
THE ROLE OF ACETYLATION IN MITOCHONDRIAL FUNCTIONI01BX001077 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI CECCHINI, GARY · 2011 to 2014
–
BLRD VA I01 BX001077BLRD VA IK6 BX004215NIDDK NIH HHS P30 DK058404NIGMS NIH HHS R01 GM061606NIGMS NIH HHS R25 GM062459NIGMS NIH HHS T32 GM008320NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

Quinol:fumarate reductase (QFR) is an integral membrane protein and a member of the respiratory Complex II superfamily. Although the structure of Escherichia coli QFR was first reported almost twenty years ago, many open questions of catalysis remain. Here we report two new crystal forms of QFR, one grown from the lipidic cubic phase and one grown from dodecyl maltoside micelles. QFR crystals grown from the lipid cubic phase processed as P1, merged to 7.5 Å resolution, and exhibited crystal packing similar to previous crystal forms. Crystals grown from dodecyl maltoside micelles processed as P2

Indexed as

Protein DomainsBinding SitesCatalytic DomainCrystallographyCrystallography, X-RayEscherichia coli ProteinsLigandsMembrane ProteinsModels, MolecularOxidoreductasesRotationEscherichia coli ProteinsLigandsMembrane ProteinsOxidoreductasesquinol fumarate reductaseCatalysisComplex IIConformational ChangeCrystallographyFumarate reductaseLipid cubic phaseMembrane proteinProtein-protein interactionRespiratory chain

Identifiers

PMID29158068
PMCPMC5835405
OpenAlexW2770152263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.